As the Pfizer deal with Biocon suggests, both sides may need partners.
因为在辉瑞制药与百康制药的合作中显示，双方都可能需要合作伙伴。
Kiran Mazumdar-Shaw, head of Biocon, says the "easy substitution" that generics firms enjoy at the pharmacy does not work with complex biosimilars—which require a doctor's approval to dispense.
百康公司总裁基朗妈祖达尔-萧说非专利药品企业享受在制药业内享受的“简单取代策略”在复杂的生物仿制制药领域将不凑效了---在生物仿制制药领域，需要有医生的批准才可以进行。
Kiran Mazumdar-Shaw, head of Biocon, says the "easy substitution" that generics firms enjoy at the pharmacy does not work with complex biosimilars—which require a doctor's approval to dispense.
百康公司总裁基朗妈祖达尔-萧说非专利药品企业享受在制药业内享受的“简单取代策略”在复杂的生物仿制制药领域将不凑效了---在生物仿制制药领域，需要有医生的批准才可以进行。
应用推荐